Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Rhythm Pharmaceuticals)"
Count: 23
Selected: 0
NCT IDTitle
NCT05194124A Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Patients With Specific Gene Defects in the Melanocortin-4 Receptor Pathway
NCT05183802An Expanded Access Protocol for Setmelanotide for Treatment of Bardet-Biedl Syndrome (BBS)
NCT05093634EMANATE: Phase 3 Study of Setmelanotide in Patients With POMC, PCSK1, LEPR, SRC1, SH2B1, or PCSK1 N221D Genetic Variants
NCT05046132Study of Setmelanotide Effects on QTc (Corrected QT) Interval in Healthy Subjects
NCT04966741Setmelanotide in Pediatric Rare Genetic Diseases of Obesity
NCT04963231DAYBREAK: Phase 2 Study in Patients With Specific Gene Defects in the MC4R Pathway
NCT04725240Open-Label Study of Setmelanotide in Hypothalamic Obesity
NCT04348175A Phase 1 Study to Evaluate the Pharmacokinetics of Setmelanotide in Subjects With Varying Degrees of Renal Impairment
NCT03746522Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Patients With Moderate to Severe Obesity
NCT03651765Long Term Extension Trial of Setmelanotide
NCT03621007An Observational,Prospective Natural History Study of Early-Onset Extreme Obesity Due to Bi-Allelic Loss-of-Function Mutations in the POMC, PCSK1 or LEPR Genes
NCT03479437The TEMPO (Tracing the Effect of the MC4 Pathway in Obesity) Registry
NCT03287960Setmelanotide for the Treatment of LEPR Deficiency Obesity
NCT03262610Setmelanotide in a Single Patient With Partial Lipodystrophy
NCT03013543Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
NCT02896192Setmelanotide for the Treatment of Early-Onset POMC Deficiency Obesity
NCT02849977Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers
NCT02431442Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RM-493 Administered to Healthy, Obese, Non-diabetic Volunteers
NCT02311673Ph 2 Trial to Evaluate Safety & Efficacy of RM-493 in Obese Patients With Prader-Willi Syndrome
NCT02041195Phase 1b/2a Study to Evaluate Safety and Efficacy of RM-493 in Obese Patients
NCT01867437Effects of RM-493 on Energy Expenditure in Obese Individuals
NCT01749137Phase 2 Study to Evaluate Safety and Efficacy of Rm-493 in Obese Patients
NCT01849705Melanocortin 4 Receptor Mutations and Obesity-associated Diseases